RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Clinical trial NCT00126672 · COMPLETED

Trial details

NCT number: NCT00126672
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nonmalignant Neoplasm Tuberous Sclerosis Lymphangioleimyomatosis Kidney Angiomyolipoma

Start date: 2005-12-20
Primary completion: 2010-04-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.